About
Sanacor is developing treatments to reverse diseases caused by Fis1 overexpression, with a lead program focused on diabetic cardiovascular disease, the leading cause of death among diabetics.
Explore Sanacor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.